Yicura Holding (HK) Limited

Immuno Cure Holding (HK) Limited is a biotechnology group focusing on its patented technology platforms for researching and developing of immunotherapy for cancers, inflammatory and infectious diseases. The patented technology platforms consist of a PD-1 based DNA vaccine technology platform aimed at targeting various infectious diseases and cancers, alongside an anti-PD-1 isoform antibody to suppress inflammation. The Group is headquartered in Hong Kong Science Park and Shenzhen. It boasts an e